The number of new models available for under $30,000 continues to shrink, but one new entry and one old one captures many of our hearts.

Roivant Sciences ROIV stock surged on Friday on positive Phase 2 results for brepocitinib in cutaneous sarcoidosis (CS), an ...

The Beacon trial enrolled 31 patients, randomizing them at a rate of 3:2:2 to receive a daily 45-mg oral dose of brepocitinib ...

HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

AbbVie has submitted applications to the FDA and EMA for new indications for upadacitinib (RINVOQ 15-mg) for the treatment of adult and adolescent patients living with non-segmental vitiligo (NSV), ...

Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both ...

1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...

Infants given acetaminophen (also called paracetamol; brand name, Tylenol) for pain or fever relief in their first year were ...

Submissions are supported by data from the Phase 3 Viti-Up clinical studies demonstrating upadacitinib achieved the co-primary endpoints of at least a 50% improvement ...

The Republic of Singapore Air Force is upgrading its C-130s and other defence hardware to build a future-ready air force by ...

Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health ...

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ...